About
Telesis Bio Inc. (PINK:TBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
May 28 2025
Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
Mar 18 2025
Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis
Sep 10 2024
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
Recent Videos

Conserto Sistema automatizado estação trabalho biologia sintética Codex DNA Telesis Bio BioXP 3250
Sep 26, 2025

Build Biology Overnight
May 02, 2025

TBIO Telesis Bio Inc. Stock Split History
Jan 09, 2025

Telesis bio Tbio short squeeze incoming delist trick patent licensing DHR not financial advice DYODD
Sep 25, 2024
Financials
Revenue
$17.03 M
Market Cap
$97.67 K
EPS
-30.42
Translate